М.В. Смолякова, Е.А. Григоренко, О. В. Калачик, Н. П. Митьковская
Белорусский государственный медицинский университет, Минский научно-практический центр хирургии, трансплантологии и гематологии
Цель: выявить факторы кардиоваскулярного риска у реципиентов трансплантата почки, а также изучить особенности лабораторно-инструментальных показателей в отдаленном послеоперационном периоде в зависимости от его течения и возникновения неблагоприятных кардиоваскулярных событий.
ключевые слова: реципиенты трансплантата почки, неблагоприятные кардиоваскулярные события, артериальная гипертензия, дислипидемия, гиперэритропоэтинемия

для цитирования: М.В. Смолякова, Е.А. Григоренко, О. В. Калачик, Н. П. Митьковская. Факторы кардиоваскулярного риска в предоперационном и отдаленном послеоперационном периоде у реципиентов трансплантата почки. Неотложная кардиология и кардиоваскулярные риски, 2020, Т. 4, № 1, С. 846–852

Cardiovascular risk factors of preoperative and long-term postoperative period in kidney transplant recipients
M.V. Smaliakova, E.A. Grigorenko, O.V. Kalachik, N.P. Mitkovskaya
The aim of the study is to identify cardiovascular risk factors in kidney transplant recipients and to analyze the laboratory and instrumental findings of the long-term postoperative period depending on its course and the occurrence of adverse cardiovascular events.
keywords: kidney transplant recipients, adverse cardiovascular events, arterial hypertension, dyslipidemia, hypererythropoietinemia

for references: M.V. Smaliakova, E.A. Grigorenko, O.V. Kalachik, N.P. Mitkovskaya. Cardiovascular risk factors of preoperative and long-term postoperative period in kidney transplant recipients. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski [Emergency cardiology and cardiovascular risks], 2020, vol. 4, no. 1, pp. 846–852

1. Pugh D., Gallacher P.J., Dhaun N. Management of Hypertension in Chronic Kidney Disease. Drugs, 2019, vol. 79, no 4, pp. 365-379.
2. Assimon M.M., Wang L., Flythe J.E. Intradialytic hypertension frequency and shortterm clinical outcomes among individuals receiving maintenance hemodialysis. Am J Hypertens, 2018, vol. 31, pp. 329-339.
3. Li Z., Lacson Jr.E., Lowrie E.G., Ofsthun N.J., Kuhlmann M.K., Lazarus J.M., Levin N.W. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis, 2006, vol. 48, pp. 606-615.
4. Ponticelli C., Cucchiari D., Graziani G. Hypertension in kidney transplant recipients. Transpl Int, 2011, vol. 24, no. 6, pp. 523-533.
5. Kasiske B.L., Anjum S., Shah R., Skogen J., Kandaswamy C., Danielson B., O’Shaughnessy E.A., Dahl D.C., Silkensen J.R., Sahadevan M., Snyder J.J. Hypertension after kidney transplantation. Am J Kidney Dis, 2004, vol. 43, no. 6, pp. 1071-1081.
6. Cano N. Nutrition de l’hémodialysé chronique. Nutr Clin et Metab, 2004, vol. 18, no. 1, pp. 7-10.
7. Tran M.-H., Foster C.E., Kalantar-Zadeh K., Ichii H. Kidney transplantation in obese patients. World J. Transplant, 2016, vol. 6, no. 1, pp. 135-143.
8. Gore J.L., Pham P.T., Danovitch G.M., Wilkinson A.H., Rosenthal J.T., Lipshutz G.S., Singer J.S. Obesity and outcome following renal transplantation. Am J Translant, 2006, vol. 6, pp. 357-363.
9. Lentine K.L., Rocca-Rey L.A., Bacchi G., Wasi N., Schmitz L., Salvalaggio P.R., Abbott K.C., Mark A.S., Neri L., Brennan D.C. Obesity and cardiac risk af ter kidney transplantation: experience at one center and comprehensive literature review. Transplantation, 2008, vol. 86, no. 2, pp. 303-312.
10. Heng A.E. Aniort J., Pereira B., Fervenza F., Boirie Y., Prieto M. Renal Transplant in Obese Patients and Impact of Weight Loss Before Surgery on Surgical and Medical Outcomes: A Single-Center Cohort Study. Exp Clin Transplant, 2019, vol. 17, no. 5, pp. 604-612.
11. Nishizawa Y., Shoji T., Ishimura E., Inaba M., Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis, 2001, vol. 38, no. 4, pp. 4-7.
12. Devine P.A., Courtney A. E., Maxwell A. P. Cardiovascular risk in renal transplant recipients. J Nephrology, 2019, vol. 32, pp. 389-399.
13. Jie K.E., Verhaar M.C., Cramer M.-J.M., van der Putten K., Gaillard C.A.J.M., Doevendans P.A., Koomans H.A., Joles J.A., Braam B. Erythropoietin and the cardiorenal syndrome: Cellular mechanisms on the cardiorenal connectors. Am J Renal Physiol, 2006, vol. 291, pp. 932-944.
14. Palazzuoli A., Silverberg D.S., Iovine F., Calabrò A., Campagna M.S., Gallotta M., Nuti R. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J, 2007, vol. 154, no. 645, pp. 9-15.
15. Ichimaru N., Obi Y., Nakazawa S., Yamanaka K., Kakuta Y., Abe T., Kaimori J.-Y., Imamura R., Nonomura N., Moriyama T., Takahara S. Post-transplant anemia has strong influences on renal and patient outcomes in living kidney transplant patients. Transplant Proc, 2016, vol. 48, no. 3, pp. 878-883.
16. Kolonko A., Pinocy-Mańdok J., Kocierz M., Kujawa-Szewieczek A., Chudek J., Malyszko J., Malyszko J.S., Myśliwiec M., Wiecek A. Anemia and erythrocytosis after kidney transplantation and 5-year graft function and survival. Transplant Proc, 2009, vol. 41, no. 8, pp. 3046-3051.
17. Malyszko J., Oberbauer R., Watschinger B. Anemia and erythrocytosis in patients after kidney transplantation. Transpl Int, 2012, vol. 25, no. 10, pp. 1013-1023.
18. Wanner C., Zimmermann J., Schwedler S., Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl, 2002, vol. 80, pp. 99-102.
19. Zhang W., He J., Zhang F., Huang C., Wu Y., Han Y., Zhang W., Zhao Y. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J Nephrol, 2013, vol. 26, no. 2, pp. 243-253.
20. Smaliakova M.V., Mitkovskaya N.P., Kalachik O.V., Kartun L.V. Faktory kardiovaskulyarnogo riska u retsipiyentov transplantata pochki v rannem posleoperatsionnom periode. Neotlozhnaya kardiologiya i kardioovaskulyarnyye riski [Cardiovaccular risk factors in renal transplant recipients in the early postoperative period]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski, 2019, vol. 3, no. 1, pp. 513-518. (in Russian).
21. Abedini S., Holme I., März W., Weihrauch G., Fellström B., Jardine A., Cole E., Maes B., Neumayer H.-H., Grønhagen-Riska C., Ambühl P., Holdaas H. Inflammation in Renal Transplantation. Clin J Am Soc Nephrol, 2009, vol. 4, no. 7, pp. 1246-1254.
22. Bakri R.S., Afzali B., Covic A., Sriskantharan R., Bharma-Ariza P., Park W.-H., Sriharan M., Dalton N., Wierzbicki A.S., Crook M.A., Goldsmith D.J.A. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Clin Transplant, 2004, vol. 18, no. 2. pp. 201-204.
Формат файла: pdf (318.06 Кб)